Exelixis (EXEL) Change in Account Payables (2016 - 2026)

Exelixis' (EXEL) quarterly Change in Account Payables came in at -$17.9 million in Q2 2026, down 310.53% year-on-year from $8.5 million in Q2 2025, and down 38.74% quarter-over-quarter from -$12.9 million in Q1 2026.

Exelixis (EXEL) Change in Account Payables (2016 - 2026) Analysis & Trends

Exelixis' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$17.9 million for Q2 2026.

  • On a quarterly basis, Change in Account Payables fell 310.53% year-over-year to -$17.9 million in Q2 2026; TTM through Apr 2026 was -$76.6 million, a 466.94% decrease from a year earlier, with the FY2026 full-year figure at -$50.2 million, down 129.15% from the prior year.
  • Change in Account Payables fell to -$17.9 million in Q2 2026 per EXEL's latest filing, from -$12.9 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $43.6 million in Q4 2023 and bottomed at -$63.5 million in Q3 2025.
  • The 5-year median for Change in Account Payables is $2.2 million (2025), against an average of -$968823.5.
  • Biggest YoY gain for Change in Account Payables was 3481.14% in 2024; the steepest drop was 8332.45% in 2024.
  • Year by year, Change in Account Payables stood at $19.8 million in 2022, then jumped by 120.68% to $43.6 million in 2023, then slumped by 39.52% to $26.4 million in 2024, then sank by 32.73% to $17.8 million in 2025, then sank by 200.8% to -$17.9 million in 2026.
  • Per Business Quant, the three latest EXEL Change in Account Payables figures stand at -$17.9 million (Q2 2026), -$12.9 million (Q1 2026), and $17.8 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -17.90 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -17.90 Mn
Apr 3, 2026 -17.90 Mn
Jan 2, 2026 -12.90 Mn
Jan 2, 2026 -12.90 Mn
Oct 3, 2025 17.76 Mn
Oct 3, 2025 17.76 Mn
Jul 4, 2025 -63.51 Mn
Jul 4, 2025 -63.51 Mn
Apr 4, 2025 8.50 Mn
Apr 4, 2025 8.50 Mn
Jan 3, 2025 2.24 Mn
Jan 3, 2025 2.24 Mn
Sep 27, 2024 26.39 Mn
Sep 27, 2024 26.39 Mn
Jun 28, 2024 -16.28 Mn
Jun 28, 2024 -16.28 Mn
Mar 29, 2024 -34.25 Mn
Mar 29, 2024 -34.25 Mn
Dec 29, 2023 43.64 Mn
Dec 29, 2023 43.64 Mn